Navigatie
Marktvooruitzichten Voorraadscreener Dividend kalender Evenementen kalender Waardering van aandelen Markten Nieuws
Probeer gratis

Pacira BioSciences

NASDAQ PCRX
$30.82 -0.69 -2.24%
Today share price
VS
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 32 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.61B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
1.99B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.05
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
52.19M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-8.65 %

Upcoming events Pacira BioSciences

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Pacira BioSciences

Stock analysis Pacira BioSciences

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
22.83 8.68
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
1.85 23.53
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
10.97 4.35
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
2.09 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
7.90 9.54

Price change Pacira BioSciences per year

47.54$ 80.00$
Min Max

Summary analysis Pacira BioSciences

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Pacira BioSciences

Revenue and net income Pacira BioSciences

All parameters

Stock news Pacira BioSciences

All news
21 december 2023 в 15:45

Pacira BioSciences Names Frank Lee as CEO

21 december 2023 в 15:45

Pacira BioSciences Names Frank Lee as CEO

26 september 2023 в 23:45

Pacira BioSciences Chairman, CEO David Stack to Retire

26 september 2023 в 23:40

Pacira BioSciences Chairman, CEO David Stack to Retire

29 maart 2023 в 15:36

Pacira BioSciences: FDA to Review Exparel in Lower Extremity Procedures >PCRX

29 maart 2023 в 15:32

Pacira BioSciences: FDA to Review Exparel in Lower Extremity Procedures >PCRX

13 oktober 2022 в 15:35

Pacira BioSciences 3Q Revenue Up on Exparel Sales

13 oktober 2022 в 15:30

Pacira BioSciences 3Q Revenue Up on Exparel Sales

21 september 2022 в 15:20

Pacira BioSciences Sees Positive Trial Results for Exparel

21 september 2022 в 15:20

Pacira BioSciences Sees Positive Trial Results for Exparel

11 oktober 2021 в 17:55

Pacira BioSciences Nears $630 Million Deal for Flexion

11 oktober 2021 в 16:00

Flexion Therapeutics Shares Soar on Pacira BioSciences Deal >FLXN

11 oktober 2021 в 16:00

Flexion Therapeutics Shares Soar on Pacira BioSciences Deal >FLXN

11 oktober 2021 в 14:25

Pacira BioSciences to Buy Flexion Therapeutics

11 oktober 2021 в 14:20

Flexion Therapeutics shares soar 39% premarket on news to be acquired by Pacira Biosciences

11 oktober 2021 в 14:20

Pacira BioSciences to Buy Flexion Therapeutics

26 juli 2021 в 18:04

Pacira BioSciences upgraded to overweight from neutral at J.P. Morgan

About company Pacira BioSciences

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a bupivacaine liposome injectable suspension, administered at the time of surgery to control pain and reduce or eliminate the use of opioids for acute postsurgical pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Parsippany, New Jersey.
Address:
5 Sylvan Way, Parsippany, NJ, United States, 07054
Company name: Pacira BioSciences
Issuer ticker: PCRX
ISIN: US6951271005
Country: VS
Exchange: NASDAQ
Currency: $
IPO date: 2011-02-03
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.pacira.com

On which stock exchange are Pacira BioSciences (PCRX) stocks traded?

Pacira BioSciences (PCRX) stocks are traded on NASDAQ.

What is the ticker of Pacira BioSciences stocks (PCRX)?

The stock ticker of Pacira BioSciences’s stocks or in other words, the code is PCRX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Pacira BioSciences (PCRX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Pacira BioSciences (PCRX) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Pacira BioSciences (PCRX) stocks traded?

Pacira BioSciences (PCRX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Pacira BioSciences (PCRX) stocks today?

The current price of Pacira BioSciences stocks on 19.05.2024 is 30.82 dollars. per share.

What is the dynamics of Pacira BioSciences (PCRX) stocks from the beginning of the year?

Pacira BioSciences (PCRX) quotes have increased by -3.69% from the beginning of the year up to 30.82 dollars. per 1 stocks.

How much did Pacira BioSciences (PCRX) stocks increase in мае 2024?

This month Pacira BioSciences (PCRX) quotes have increased by 14.36% to 30.82 dollars. per share.

How much are Pacira BioSciences (PCRX) stocks worth?

Today, on October, 19.05.2024 Pacira BioSciences’s (PCRX) stocks cost 30.82 dollars..

What is the market capitalization of Pacira BioSciences (PCRX)?

Capitalization is the market value of Pacira BioSciences (PCRX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 19.05.2024, the market capitalization of Pacira BioSciences (PCRX) is estimated at about 1608588260 dollars.